Article Text

Download PDFPDF
Results of a pilot screening programme for genital and extragenital gonococcal and chlamydial infections in a military population following the repeal of ‘Don't Ask, Don't Tell’
  1. Tida Lee1,
  2. Anuradha Ganesan1,2
  1. 1 Walter Reed National Military Medical Center, Bethesda, Maryland, USA
  2. 2 Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
  1. Correspondence to Anuradha Ganesan, Walter Reed National Military Medical Center, Division of Infectious Diseases, 8901, Wisconsin Avenue, Bethesda, MD 20889, USA;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In the care of the active duty HIV-positive population, there has been a shift in evaluation and data with the Department of Defense repeal of the ‘don't ask, don't tell’ (DADT) policy in September 2011.1 DADT allowed homosexual persons to serve in the military, but made it unlawful for service members to be asked about their orientation or for them to reveal their orientation. This policy made it difficult to screen for asymptomatic rectal and pharyngeal STIs. Since the repeal, service members are now able to reveal their sexual orientation without concern for repercussion.

Since September 2011, additional nucleic acid amplification test based screening of rectal and pharyngeal Neisseria gonorrhoeae (NG)/Chlamydia trachomatis (CT) was offered to patients at their biannual visits to the Walter Reed National Military Medical Center Infectious Disease Clinic. We performed retrospective analysis to …

View Full Text


  • This work was presented in part at the IDWeek 2012, San Diego, 17–21 October 2012, Abstract number 977.

  • Contributors TL and AG contributed to the conception and design of the data, analysis and interpretation of data, participated in drafting, revising and final approval of the version for publication.

  • Funding Support for this work (IDCRP-000-26) was provided by the Infectious Disease Clinical Research Program, a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Inter-Agency Agreement Y1-AI-5072.

  • Disclaimer The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of the NIH or the Department of Health and Human Services, the DoD or the Departments of the Army, Navy or Air Force. Mention of trade names, commercial products or organisations does not imply endorsement by the U.S. Government. Some authors on this paper are military service members and/or employees of the U.S. Government. As such, this work was prepared as part of official duties. Title 17 U.S.C. 105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. 101 defines a United States Government work as a work prepared by a military service member or employee of the United States Government as part of that person's official duties.

  • Competing interests None.

  • Ethics approval Walter Reed National Military Medical Center Institutional Review Board.

  • Provenance and peer review Not commissioned; externally peer reviewed.